Published in Br J Vener Dis on June 01, 1972
Frequency of N. gonorrhoeae, T. vaginalis, and C. albicans in female venereological patients. A one-year study. Br J Vener Dis (1975) 1.47
Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro. Br J Vener Dis (1976) 1.35
Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation. Br J Vener Dis (1974) 1.33
Metronidazole-resistant Trichomonas vaginalis. Br J Vener Dis (1979) 1.28
Trichomonas vaginalis. II. Laboratory investigations in trichomoniasis. Br J Vener Dis (1973) 1.12
[The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections]. Ann Inst Pasteur (Paris) (1959) 12.23
The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol (1957) 9.25
Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration. Br J Vener Dis (1961) 7.56
Laboratory studies with the systemic trichomonacide, metronidazole. J Clin Pathol (1961) 3.98
Antiprotozoan activity of nitroimidazoles. Arzneimittelforschung (1969) 1.09
A factor in serum of human beings and animals that destroys T. vaginalis. Proc Soc Exp Biol Med (1958) 1.03
Studies on antiprotozoans. 3. Isolation, identification and quantitative determination in humans of the metabolites of a new trichomonacidal agent. Biochem Pharmacol (1971) 1.00
"Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol (1966) 9.65
Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol (1976) 3.13
Prevalence of nine different micro-organisms in the female genital tract. A comparison between women from a venereal disease clinic and from a health control department. Br J Vener Dis (1979) 2.52
Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol (1978) 2.37
Influence of the alternate complement pathway in opsonization of several bacterial species. Infect Immun (1974) 2.34
Protein A mutants of Staphylococcus aureus. J Bacteriol (1971) 2.32
"Protein A" from Staphylococcus aureus. 3. Reaction with rabbit gamma-globulin. J Immunol (1967) 2.22
Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology (1974) 2.08
Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis (1974) 2.06
Effect of antibiotics of chemotaxis of human leukocytes. Antimicrob Agents Chemother (1977) 2.04
Protein A from Staphylococcus aureus. 8. Production of protein A by bacterial and L-forms of S. aureus. Acta Pathol Microbiol Scand (1969) 1.86
Group B streptococci in venereal disease clinic patients. Br J Vener Dis (1975) 1.82
Protein A from Staphylococcus aureus. VII. Physicochemical and immunological characterization. Acta Pathol Microbiol Scand (1969) 1.74
Effects of staphylococcal protein A on heat labile opsonins. J Immunol (1974) 1.73
Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci (1974) 1.62
Erythromycin-resistant Campylobacters. Lancet (1978) 1.56
Studies in venereal disease. I. Isolation of L-phase organisms of N. gonorrhoeae from patients with gonorrhoea. Br J Vener Dis (1972) 1.55
Protein A from Staphylococcus aureus. VI. Reaction with subunits from guinea pig gamma-1- and gamma-2-globulin. J Immunol (1968) 1.39
Antibiotics and suppression of lymphocyte function in vitro. Antimicrob Agents Chemother (1979) 1.38
Many bacterial species bind human IgD. J Immunol (1979) 1.34
Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation. Br J Vener Dis (1974) 1.33
THE EFFECT OF EXERCISE ON RENAL PLASMA FLOW IN NORMAL MALE SUBJECTS. J Clin Invest (1948) 1.33
4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother (1987) 1.33
Metronidazole-resistant Trichomonas vaginalis. Br J Vener Dis (1979) 1.28
Tinidazole--a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose. Br J Vener Dis (1974) 1.28
Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect (2011) 1.27
Studies of the alternate pathway in chelated serum. J Lab Clin Med (1975) 1.26
Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun (1991) 1.25
Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine (2000) 1.25
Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother (1986) 1.24
Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol (1990) 1.22
Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother (1987) 1.21
Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun (1991) 1.20
Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis (1985) 1.20
Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol (1986) 1.19
"Protein A" from Staphylococcus aureus. IV. Production of anaphylaxis-like cutaneous and systemic reactions in non-immunized guinea-pigs. J Immunol (1968) 1.18
Protein D, the immunoglobulin D-binding protein of Haemophilus influenzae, is a lipoprotein. Infect Immun (1992) 1.18
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates. Scand J Infect Dis (1985) 1.16
Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do. Antimicrob Agents Chemother (1990) 1.16
Effect of normally occurring rabbit antibodies on fluorescent-antibody reactions. J Bacteriol (1966) 1.15
Antimicrobial susceptibility of group B streptococci. Eur J Clin Microbiol (1986) 1.14
Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun (1994) 1.10
Tetracyclines and host-defense mechanisms. Antimicrob Agents Chemother (1973) 1.10
Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni, and its clinical application. Acta Pathol Microbiol Immunol Scand B (1982) 1.09
Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study. Scand J Gastroenterol (1997) 1.07
Sexually-transmitted diseases in women. Br J Vener Dis (1974) 1.06
Antibiotic-host defence interactions in vitro and in vivo. Scand J Infect Dis Suppl (1980) 1.04
The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J Infect Dis (2001) 1.04
Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter (2001) 1.03
The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains. Infect Immun (1995) 1.03
Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol (2001) 1.02
4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction. Mutat Res (1989) 1.02
Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun (1994) 1.01
Fragmentation heterogeneity of 23S ribosomal RNA in Haemophilus species. Gene (1999) 1.01
Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res (1977) 1.00
Effect of protein A on adsorption of bacteriophages to Staphylococcus aureus. J Virol (1974) 1.00
Mycobacterium marinum wrist arthritis: local and systematic dissemination caused by concomitant immunosuppressive therapy. Scand J Infect Dis (1998) 1.00
Protein D expression promotes the adherence and internalization of non-typeable Haemophilus influenzae into human monocytic cells. Microb Pathog (2001) 1.00
Antinuclear antibodies during Puva therapy. Acta Derm Venereol (1979) 1.00
Effect of rifampin on the immune response in mice. Infect Immun (1980) 0.99
Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc Natl Acad Sci U S A (1989) 0.99
Identification of a human lactoferrin-binding protein in Staphylococcus aureus. J Med Microbiol (1992) 0.99
Role of protein A in the serum-soft agar technique. Infect Immun (1972) 0.99
Effect of doxycycline on immune response in mice. Infect Immun (1985) 0.98
Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin. Immunopharmacology (1994) 0.98
Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect Immun (1996) 0.98
Protein A from Staphylococcus aureus. V. Reaction with guinea pig gamma-globulins. J Immunol (1968) 0.97
Antimicrobial activity of fosfomycin in vitro. J Antimicrob Chemother (1983) 0.97
Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures. J Infect Dis (1999) 0.96
Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scand J Infect Dis Suppl (1985) 0.96
Single dose doxycycline prophylaxis and peroperative bacteriological culture in elective colorectal surgery. Br J Surg (1981) 0.96
Evaluation of culture methods for isolation of group B streptococci. Diagn Microbiol Infect Dis (1987) 0.95
Binding of HLA antigen-containing liposomes to bacteria. Proc Natl Acad Sci U S A (1978) 0.95
Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood. Infect Immun (1983) 0.95
Superinduction of cytokine gene transcription by ciprofloxacin. J Immunol (1994) 0.95
Pathogenicity of Staphylococcus aureus mutants in general and local infections. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.94
The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate. Infect Immun (1997) 0.93
An IgM monoclonal protein with multiple serological specificities. Clin Exp Immunol (1979) 0.93
Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab (1980) 0.93
Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand J Infect Dis (1986) 0.92
Human lactoferrin binding in clinical isolates of Staphylococcus aureus. J Med Microbiol (1991) 0.92
Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection. Clin Diagn Lab Immunol (1995) 0.92
Effect of fusidic acid on the immune response in mice. Infect Immun (1980) 0.92
First clinical isolate of highly fluoroquinolone-resistant Escherichia coli in Scandanavia. Eur J Clin Microbiol Infect Dis (1990) 0.90
Identification and antibiotic prophylaxis of high-risk patients in elective colorectal surgery. World J Surg (1987) 0.90
Effect of ciprofloxacin on phagocytosis. Eur J Clin Microbiol (1985) 0.89
Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains. Infect Immun (1993) 0.89
Age-related variations in anti-streptococcal antibody levels. Eur J Clin Microbiol Infect Dis (1989) 0.89
Prevention of bacteriophage adsorption to Staphylococcus aureus by immunoglobulin G. J Virol (1974) 0.89
Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp. APMIS (1990) 0.89
Lactoferrin-binding proteins in Shigella flexneri. Infect Immun (1992) 0.89
Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection. Eur J Clin Microbiol (1986) 0.89
Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur J Clin Microbiol (1987) 0.89
Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections. J Clin Microbiol (1990) 0.88
A short antibiotic course given in conjunction with and after catheter removal consecutive to transurethral prostatic resection. Scand J Urol Nephrol (1984) 0.88
Limited effects of temafloxacin compared with ciprofloxacin on T-lymphocyte function. Antimicrob Agents Chemother (1994) 0.88
Antimicrobial agents and host defence. Scand J Infect Dis Suppl (1984) 0.87
Intra- and interstrain differences of virulence among nontypeable Haemophilus influenzae strains. APMIS (1998) 0.87
Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. APMIS (1991) 0.86
Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli. Antimicrob Agents Chemother (1991) 0.86